Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Syneos Health Inc (SYNH)
Syneos Health Inc (SYNH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,311,716
  • Shares Outstanding, K 103,647
  • Annual Sales, $ 5,393 M
  • Annual Income, $ 266,500 K
  • 60-Month Beta 1.62
  • Price/Sales 0.80
  • Price/Cash Flow 6.19
  • Price/Book 1.24
Trade SYNH with:

Options Overview Details

View History
  • Implied Volatility 3.52% ( +0.38%)
  • Historical Volatility 35.27%
  • IV Percentile 2%
  • IV Rank 1.87%
  • IV High 111.48% on 02/14/23
  • IV Low 1.47% on 05/15/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 1,572
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 18,939
  • Open Int (30-Day) 28,893

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.64
  • Number of Estimates 5
  • High Estimate 0.67
  • Low Estimate 0.59
  • Prior Year 1.13
  • Growth Rate Est. (year over year) -43.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.00 +12.43%
on 04/27/23
42.09 -1.16%
on 05/11/23
+3.88 (+10.29%)
since 04/26/23
3-Month
32.74 +27.06%
on 03/15/23
43.35 -4.04%
on 02/27/23
+3.73 (+9.85%)
since 02/24/23
52-Week
22.89 +81.71%
on 11/04/22
79.77 -47.85%
on 08/01/22
-30.32 (-42.16%)
since 05/26/22

Most Recent Stories

More News
FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health

/PRNewswire/ -- FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based...

SYNH : 41.60 (+0.05%)
Syneos Health (SYNH) Tops Q1 Earnings, Announces Merger Plan

Syneos Health's (SYNH) first-quarter 2023 earnings and revenues beat estimates. The company enters into a definitive merger agreement to be acquired by a private investment consortium.

SYNH : 41.60 (+0.05%)
JNJ : 154.35 (-0.04%)
ISRG : 306.90 (+1.03%)
EW : 82.01 (+0.44%)
Syneos Health (SYNH) Announces a $7.1 Billion Merger Agreement

Syneos Health (SYNH) is set to become private company following a $7.1 billion merger deal to be acquired by a private investment consortium.

SYNH : 41.60 (+0.05%)
AXDX : 0.7377 (+2.46%)
PEN : 306.50 (+0.52%)
SIBN : 24.27 (-1.10%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Syneos Health, Inc.

/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Syneos Health, Inc. (NASDAQ: SYNH) and its board of directors...

SYNH : 41.60 (+0.05%)
Shareholder Alert: Ademi LLP investigates whether Syneos Health, Inc. has obtained a Fair Price in its transaction with the Investment Consortium

/PRNewswire/ -- Ademi LLP is investigating Syneos Health (Nasdaq: SYNH) for possible breaches of fiduciary duty and other violations of law in its transaction...

SYNH : 41.60 (+0.05%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTIC, LTHM, SYNH, FRG

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CTIC : 9.05 (+0.33%)
LTHM : 23.90 (+1.23%)
SYNH : 41.60 (+0.05%)
FRG : 29.17 (unch)
Syneos Health (SYNH) Q1 Earnings and Revenues Surpass Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 11.94% and 6.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 41.60 (+0.05%)
NYXH : 7.90 (+1.41%)
Stock Index Futures Move Lower Ahead of U.S. Inflation Data, Debt Ceiling Worries Weigh

June S&P 500 futures (ESM23) are down -0.20%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.23% this morning as investors looked ahead to a crucial U.S. inflation report that could provide fresh...

ESM23 : 4,213.25s (+1.29%)
NQM23 : 14,332.50s (+2.55%)
PYPL : 60.22 (+1.43%)
SWKS : 105.05 (+5.07%)
DVA : 94.28 (-0.82%)
ABNB : 106.81 (+2.29%)
ACA.P.DX : 11.938 (+1.00%)
ABN.A.DX : 14.470 (-0.48%)
UPST : 24.87 (+4.80%)
TWLO : 60.10 (+1.73%)
RIVN : 15.14 (+3.91%)
SYNH : 41.60 (+0.05%)
Computer Programs and Systems (CPSI) Misses Q1 Earnings Estimates

Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of -23.68% and 2.05%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the...

CPSI : 24.42 (+0.33%)
SYNH : 41.60 (+0.05%)
Here's Why Investors Should Retain Syneos Health (SYNH) for Now

Syneos Health's (SYNH) share price movement is expected to be favorable due to the strength of the company's Syneos One portfolio and several value-added partnership deals.

SYNH : 41.60 (+0.05%)
HOLX : 79.03 (+0.66%)
PODD : 272.63 (-1.60%)
ZBH : 127.65 (-0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Syneos Health, Inc. is a key global biopharmaceutical solutions company offering a broad range of clinical and commercial facilities. The company majorly serves customers in the biopharmaceutical, biotechnology and medical device industries. Through its Contract Research Organization (CRO) and Contract...

See More

Key Turning Points

3rd Resistance Point 41.88
2nd Resistance Point 41.79
1st Resistance Point 41.69
Last Price 41.60
1st Support Level 41.50
2nd Support Level 41.41
3rd Support Level 41.31

See More

52-Week High 79.77
Fibonacci 61.8% 58.04
Fibonacci 50% 51.33
Fibonacci 38.2% 44.62
Last Price 41.60
52-Week Low 22.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar